Inventor · disambiguated record
Chunqiu Lai
Also filed as: LAI CHUNQIU · LAI CHUNQIU C
14 granted patents·16 pending applications·24 citations·filing 2003–2024
88Inventor score
Top patents by PatentIndex Score
30 records- 0189US10676485B2Macrocyclic MCL-1 inhibitors and methods of useABBVIE INC·Filed 2018·Granted Jun 9, 2020·2 cites·2 claims
- 0286US2025313572A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2024·Application pending·0 cites
- 0383US9718821B2Pyridopyrimidinone inhibitors of kinasesABBVIE INC·Filed 2013·Granted Aug 1, 2017·8 cites·1 claims
- 0482US2024228509A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2023·Application pending·0 cites
- 0581US2025092062A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2024·Application pending·0 cites
- 0679US9051327B2Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinasesABBVIE INC·Filed 2014·Granted Jun 9, 2015·2 cites·10 claims
- 0778US8969375B2CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted Mar 3, 2015·2 cites·17 claims
- 0878US2023399340A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2022·Application pending·0 cites
- 0977US2022259226A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2022·Application pending·0 cites
- 1076US9650358B2Pyridine CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted May 16, 2017·1 cites·18 claims
- 1176US9181239B2Pyridopyrimidinone inhibitors of kinasesABBVIE INC·Filed 2012·Granted Nov 10, 2015·2 cites·22 claims
- 1275US2023183261A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2022·Application pending·0 cites
- 1371US8383624B2Pyrrolopyrazine inhibitors of kinasesABBOTT LAB·Filed 2010·Granted Feb 26, 2013·2 cites·11 claims
- 1470US9181246B2Pyrrolopyridine inhibitors of kinasesABBVIE INC·Filed 2014·Granted Nov 10, 2015·1 cites·21 claims
- 1570US2021292339A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2020·Application pending·0 cites
- 1669US7521439B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2006·Granted Apr 21, 2009·1 cites·12 claims
- 1768US2020325153A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2020·Application pending·0 cites
- 1867US8435980B2Pyrrolopyridine inhibitors of kinasesFLORJANCIC ALAN S·Filed 2010·Granted May 7, 2013·2 cites·15 claims
- 1965US2020255451A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 2065US2019055264A1Macrocyclic MCL-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 2165US2020239494A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 2264US2020010480A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2019·Application pending·0 cites
- 2356US7141559B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2003·Granted Nov 28, 2006·1 cites·21 claims
- 2454US2018193315A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2018·Application pending·0 cites
- 2553US2018071262A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2017·Application pending·0 cites
- 2652US8822446B2Pyrrolopyridine inhibitors of kinasesPENNING THOMAS D·Filed 2011·Granted Sep 2, 2014·0 cites·19 claims
- 2749US9328112B2Tetracyclic CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted May 3, 2016·0 cites·9 claims
- 2847US2016235716A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2015·Application pending·0 cites
- 2946US2006264433A1Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)BACKES BRADLEY J·Filed 2006·Application pending·0 cites
- 3040US9796708B2Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted Oct 24, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Chunqiu Lai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →